Natera Ovarian Cancer Detection Assay

TerminatedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

December 14, 2017

Primary Completion Date

November 1, 2019

Study Completion Date

December 31, 2019

Conditions
Adnexal Mass
Trial Locations (1)

15213

Magee-Women's Hospital of UPMC, Pittsburgh

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Natera, Inc.

INDUSTRY

NCT03485651 - Natera Ovarian Cancer Detection Assay | Biotech Hunter | Biotech Hunter